Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 USD | +29.55% | +31.54% | +189.83% |
21/05 | DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis | CI |
21/05 | Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+189.83% | 53.07M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.49% | 21.96B | |
-8.77% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- DRRX Stock
- News DURECT Corporation
- HC Wainwright Trims Price Target on Durect to $32 From $35, Maintains Buy Rating